Entero Healthcare Solutions Limited IPO
MainboardPharmacy Retail
Listed On: Feb 16, 2024 at ₹ 1228.70(NSE)
₹ 13838 /11 Shares
Check AllotmentPrice Summary
Last Closing
1,246.30 (-0.93%)52 Week High
1,584.2552 Week Low
1,080.00Last Update
15-Jul-2025 3:30 PM09 Feb, 2024
Open Date13 Feb, 2024
Close Date14 Feb, 2024
Allotment Date16 Feb, 2024
Listing DateIssue Price
₹1195-1258 per equity shareFace Value
₹10 Per Equity ShareListing at Group
BSE, NSERegistrar
Link Intime India Private LtdList Price
1228.70(NSE)Listing Date
2024-02-16Market Lot
Retail : 11 Shares (₹13,838/-)S-HNI : 165 Shares (₹2,07,570/-)
B-HNI : 803 Shares (₹10,10,174/-)
Lead Manager
ICICI Securities LimitedDam Capital Advisors Ltd (Formerly Idfc Securities Ltd)
Jefferies India Private Limited
Jm Financial Limited
SBI Capital Markets Limited
Issue Size
Total ₹1600 Cr :#Fresh Issue : 7,949,125 shares(aggregating up to ₹1000.00 Cr) +
#OFS : 4,769,475 shares of ₹10(aggregating up to ₹600.00 Cr)
Retail Portion
10% (Number of Retail Applications: 1,15,046 Approx),(Number of S-HNI Applications : 3,835 Approx),
(Number of B-HNI Applications : 7,670 Approx)
Subscription
1.53 timesEntero Healthcare Solutions Limited IPO Details
Entero Healthcare Solutions Limited IPO is a book-built issue of ₹1600 crores, The total issue size is ₹1600 crores. The IPO of Entero Healthcare Solutions Limited is priced at ₹1195-1258 per equity share, which has a face value of ₹10 Per Equity Share each, IPO bidding starts from Feb 9, 2024 and ends on Feb 13, 2024. The allotment for Entero Healthcare Solutions Limited IPO will be finalized on Feb 14, 2024. Entero Healthcare Solutions Limited IPO will be listed on BSE, NSE, with a tentative listing date fixed as Feb 16, 2024. The company shall list its equity shares on the BSE, NSE. Link Intime India Private Ltd is the registrar of the issue.
Retail investors can bid for a minimum of 11 shares, extendable to 13,838. S-HNIs will be able to bid for 165 shares at ₹2,07,570, while B-HNIs can also apply for a bid of 803 shares at ₹10,10,174. The book-running lead manager for the IPO is/are ICICI Securities Limited , Dam Capital Advisors Ltd (Formerly Idfc Securities Ltd) , Jefferies India Private Limited , Jm Financial Limited , SBI Capital Markets Limited .
The total issue ₹1600 crore, comprising a fresh issue of 79,49,125 shares ₹1000 crore and an Offer for Sale (OFS) of 47,69,475 shares to mop up ₹600 crore.
The Entero Healthcare Solutions Limited IPO sets its price band at 1195-1258 for each share. A single application for Entero Healthcare Solutions Limited IPO must contain at least 11 shares. Sentiment investors need to invest a minimum of 11 through their retail account. For investors to prevent oversubscription issues, they should submit bids at the cutoff price, which estimates about ₹13,838 In order to participate in the sNII, investors must purchase at least 15 lots of 165 shares for ₹2,07,570, while the bNII requires 73 lots of 803 shares for an investment of ₹10,10,174.
Entero Healthcare Solutions Limited IPO Subscription Details
| As on | QIB | NII bNII sNII | Retail | Employee | Total |
|---|---|---|---|---|---|
| Shares Offered / Reserved | 37,96,502 | 18,98,251 12,65,501 6,32,750 | 18,98,251 | 70,625 | 76,63,629 |
| Day 1 - 09-02-24 05:00 PM | 0.00 x | 0.04 0.03 x 0.08 x | 0.32 x | 0.36 x | 0.09 x |
| Day 2 - 12-02-24 05:00 PM | 0.00 x | 0.09 0.05 x 0.17 x | 0.88 x | 0.77 x | 0.19 x |
| Day 3 - 13-02-24 05:00 PM | 2.28 x | 0.22 0.16 x 0.33 x | 1.33 x | 1.25 x | 1.53 x |
Entero Healthcare Solutions Limited Valuations
EPS Pre IPO
₹0.00/-EPS Post IPO
₹9.70/-P/E Pre IPO
0P/E Post IPO
129.75ROE
-2.66%ROCE
6.06%Debt/Equity
0.45RoNW
-1.86%Price to Book Value
7.22Entero Healthcare Solutions Limited Company Financials All values are in ₹ Cr.
| 31-Mar-23 | 31-Mar-22 | 31-Mar-21 | |
|---|---|---|---|
| Assets | 1,308.73 | 1,125.98 | 833.79 |
| Revenue | 3,305.72 | 2,526.55 | 1,783.67 |
| Profit After Tax | -11.10 | -29.44 | -15.35 |
| Net Worth | 597.66 | 563.22 | 487.06 |
| Total Borrowing | 373.52 | 285.03 | 141.70 |
About The Company
Entero Healthcare Solutions Limited is a distributor of healthcare products in India. The company's technology-driven platform provides healthcare product distribution services to pharmacies, hospitals, and clinics throughout India.
During the fiscal years 2021, 2022, and 2023, the company served over 39,500, 64,200, and 81,400 retail customers, respectively. Additionally, they also served over 1,600, 2,500, and 3,400 hospital customers during the same period.
Entero Healthcare Solutions has relationships with over 1,900 healthcare product manufacturers, giving them access to over 64,500 product stock-keeping units as of March 31, 2023.
The company has 73 warehouses in 37 cities across 19 states and union territories, and its customer base includes over 81,400 pharmacies and 3,400 hospitals in 495 districts as of March 31, 2023. This provides excellent access to healthcare product manufacturers.
As of 31st March, 2023, the company employs a total of 3014 people in various departments.
Entero Healthcare Solutions Limited - Promoter(s)
Pre Issue Share Holding: 77.11%
Post Issue Share Holding: N/A%
- Prabhat Agrawal
- Prem Sethi
- OrbiMed Asia III Mauritius Limited
Entero Healthcare Solutions Limited IPO - Issue Objectives
- Repayment/prepayment, in full or part, of certain borrowings availed of by the company and our Subsidiaries.
- Funding the long term working capital requirements.
- Pursuing inorganic growth initiatives through acquisitions.
- General corporate purposes.
Entero Healthcare Solutions Limited IPO - Anchor Investors
Global marquee investors Smallcap World Fund Inc, Government of Singapore, Monetary Authority of Singapore, Carmignac Portfolio, CLSA Global, Societe Generale, Morgan Stanley, Goldman Sachs, and Copthall Mauritius Investment participated in the anchor book.
Among others, Amundi Funds, Jupiter India Fund, SBI General Insurance Company, Private Client Emerging Markets Portfolio, Magna Umbrella Fund, Bajaj Allianz Life Insurance, TT Emerging Markets Unconstrained Fund, and Allianz Global Investors Fund also invested in the company through anchor book.
Other Details
Entero Healthcare Solutions Limited
Plot No. I-35, Building - B, Industrial Area Phase - I, 13/7 Mathura Road, Faridabad 121 003Phone: +91 22-69019100
Email: jayant.prakash@enterohealthcare.com
Website: https://www.enterohealthcare.com/
Link Intime India Private Ltd
Phone: +91-22-4918 6270
Email: enterohealthcare.ipo@linkintime.co.in
Website: https://linkintime.co.in/Initial_Offer/public-issues.html
Entero Healthcare Solutions Limited IPO - FAQs
Ans. Entero Healthcare Solutions Limited IPO is a Mainboard IPO. The issue is priced at ₹1195-1258 per equity share. The minimum order quantity is 11 Shares. The IPO opens on Feb 9, 2024, and closes on Feb 13, 2024. Link Intime India Private Ltd is the registrar for the IPO. The shares are proposed to be listed on BSE, NSE.
Ans. The Entero Healthcare Solutions Limited IPO opens on Feb 9, 2024 and closes on Feb 13, 2024.
Ans. The size of Entero Healthcare Solutions Limited IPO is Total ₹1600 Cr : #Fresh Issue : 7,949,125 shares(aggregating up to ₹1000.00 Cr) + #OFS : 4,769,475 shares of ₹10(aggregating up to ₹600.00 Cr).
Ans. The IPO price band is set between ₹1195-1258 per equity share.
Ans. To apply for Entero Healthcare Solutions Limited IPO IPO, follow the steps given below:
- - Open the IPO Ji App or Website
- - Find Entero Healthcare Solutions Limited IPO in the List of IPOs
- - Press "Apply" Button
- - Select Your Demat Account
- - Select Your Shares Quantity and Submit
- - Track Your IPO Status
Ans. The share allotment date of Entero Healthcare Solutions Limited IPO is Feb 14, 2024.
Ans. The Entero Healthcare Solutions Limited IPO will be listed on Feb 16, 2024.
Ans. Follow the steps to check the allotment status for Entero Healthcare Solutions Limited IPO here.
